Suchergebnisse - "Ader, Florence"

PubPharm (22)

1

Comparison of mortality and outcomes of four respiratory viruses in the intensive care unit : a multicenter retrospective study

enthalten in: Scientific reports | 2024

von Grangier, B. | Vacheron, C. | De Marignan, D. | +28

2

Legionnaires Disease in Solid Organ Transplant Recipients : A Decade-Long Nationwide Study in France

enthalten in: Chest | 2024

von Thizy, G. | Flahault, A. | Scemla, A. | +40

3

Encephalitis in HIV-negative immunodeficient patients : a prospective multicentre study, France, 2016 to 2019

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Landré, S. | Ader, F. | Epaulard, O. | +4

4

Suboptimal exposure to fluconazole in critically ill patients : Pharmacokinetic analysis and determinants

enthalten in: Infectious diseases now | 2023

von Bienvenu, A. | Pradat, P. | Matusik, E. | +20

5

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct) : a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care (London, England) | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +154

6

Impact of COVID-19 pandemic on antifungal consumption : a multicenter retrospective analysis

enthalten in: Critical care (London, England) | 2022

von Bienvenu, A. | Bestion, A. | Pradat, P. | +26

7

Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies : a multicentre observational study

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Paret, R. | Le Bourgeois, A. | Guillerm, G. | +11

8

Prognosis and factors associated with disseminated nocardiosis : a ten-year multicenter study

enthalten in: The Journal of infection | 2022

von Soueges, S. | Bouiller, K. | Botelho-Nevers, E. | +10

9

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy) : a phase 3, randomised, controlled, open-label trial

enthalten in: The Lancet. Infectious diseases | 2022

von Ader, F. | Bouscambert-Duchamp, M. | Hites, M. | +115

CommentIn: Lancet Infect Dis. 2021 Sep 14;:null. - PMID 34534513

10

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887